Penumbra Basic EPS 2014-2025 | PEN
Penumbra annual/quarterly basic eps history and growth rate from 2014 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- Penumbra basic eps for the quarter ending June 30, 2025 was $1.17, a 175.48% decline year-over-year.
- Penumbra basic eps for the twelve months ending June 30, 2025 was $3.82, a 879.49% increase year-over-year.
- Penumbra annual basic eps for 2024 was $0B, a 84.81% decline from 2023.
- Penumbra annual basic eps for 2023 was $0.002B, a 4840% decline from 2022.
- Penumbra annual basic eps for 2022 was $-0B, a 135.71% decline from 2021.
| Penumbra Annual Basic EPS | |
|---|---|
| 2024 | $0.36 |
| 2023 | $2.37 |
| 2022 | $-0.05 |
| 2021 | $0.14 |
| 2020 | $-0.44 |
| 2019 | $1.39 |
| 2018 | $0.19 |
| 2017 | $0.14 |
| 2016 | $0.49 |
| 2015 | $0.09 |
| 2014 | $-0.18 |
| 2013 | $0.21 |
| Penumbra Quarterly Basic EPS | |
|---|---|
| 2025-06-30 | $1.17 |
| 2025-03-31 | $1.02 |
| 2024-12-31 | $0.87 |
| 2024-09-30 | $0.76 |
| 2024-06-30 | $-1.55 |
| 2024-03-31 | $0.28 |
| 2023-12-31 | $1.42 |
| 2023-09-30 | $0.24 |
| 2023-06-30 | $0.49 |
| 2023-03-31 | $0.22 |
| 2022-12-31 | $0.11 |
| 2022-09-30 | $-0.06 |
| 2022-06-30 | $-0.10 |
| 2022-03-31 | $0.00 |
| 2021-12-31 | $-0.67 |
| 2021-09-30 | $0.24 |
| 2021-06-30 | $0.25 |
| 2021-03-31 | $0.32 |
| 2020-12-31 | $0.10 |
| 2020-09-30 | $-0.24 |
| 2020-06-30 | $-0.34 |
| 2020-03-31 | $0.04 |
| 2019-12-31 | $0.27 |
| 2019-09-30 | $0.33 |
| 2019-06-30 | $0.48 |
| 2019-03-31 | $0.31 |
| 2018-12-31 | $0.19 |
| 2018-09-30 | $-0.55 |
| 2018-06-30 | $0.39 |
| 2018-03-31 | $0.16 |
| 2017-12-31 | $0.28 |
| 2017-09-30 | $0.01 |
| 2017-06-30 | $-0.05 |
| 2017-03-31 | $-0.10 |
| 2016-12-31 | $-0.08 |
| 2016-09-30 | $0.39 |
| 2016-06-30 | $0.10 |
| 2016-03-31 | $0.08 |
| 2015-12-31 | $0.06 |
| 2015-09-30 | $0.04 |
| 2015-06-30 | $-0.11 |
| 2015-03-31 | $0.10 |
| 2014-12-31 | |
| 2014-09-30 | $-0.25 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.364B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $176.126B | 21.31 |
| Intuitive Surgical (ISRG) | United States | $170.993B | 70.88 |
| IDEXX Laboratories (IDXX) | United States | $51.626B | 53.45 |
| Edwards Lifesciences (EW) | United States | $46.482B | 30.83 |
| Alcon (ALC) | Switzerland | $42.192B | 28.51 |
| IQVIA Holdings (IQV) | United States | $31.268B | 17.67 |
| DexCom (DXCM) | United States | $29.592B | 44.39 |
| Mettler-Toledo (MTD) | United States | $25.624B | 30.41 |
| STERIS (STE) | Ireland | $22.022B | 24.25 |
| Waters (WAT) | United States | $16.738B | 22.99 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.353B | 0.00 |
| Hologic (HOLX) | United States | $15.084B | 16.34 |
| Sysmex ADR (SSMXY) | Japan | $10.519B | 29.84 |
| Masimo (MASI) | United States | $8.885B | 29.96 |
| Globus Medical (GMED) | United States | $7.262B | 17.30 |
| Teleflex (TFX) | United States | $5.076B | 8.19 |
| Glaukos (GKOS) | United States | $5.050B | 0.00 |
| TransMedics (TMDX) | United States | $4.287B | 65.15 |
| Integer Holdings (ITGR) | United States | $3.774B | 18.83 |
| PROCEPT BioRobotics (PRCT) | United States | $2.662B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.323B | 13.83 |
| Alphatec Holdings (ATEC) | United States | $2.270B | 0.00 |
| Veracyte (VCYT) | United States | $1.959B | 27.48 |
| Nihon Kohden (NHNKY) | Japan | $1.942B | 22.27 |
| Elekta AB (EKTAY) | Sweden | $1.839B | 16.53 |
| Artivion (AORT) | United States | $1.373B | 128.60 |
| Pulse Biosciences (PLSE) | United States | $1.026B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.009B | 0.00 |
| OPKO Health (OPK) | United States | $1.000B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.992B | 5.68 |
| IRadimed (IRMD) | United States | $0.885B | 42.94 |
| Beta Bionics (BBNX) | United States | $0.687B | 0.00 |
| SiBone (SIBN) | United States | $0.682B | 0.00 |
| AxoGen (AXGN) | United States | $0.625B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.516B | 4.15 |
| OrthoPediatrics (KIDS) | United States | $0.490B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.482B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.457B | 8.11 |
| Pacific Biosciences Of California (PACB) | United States | $0.426B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.352B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.352B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.316B | 8.03 |
| RxSight (RXST) | United States | $0.311B | 0.00 |
| Neuronetics (STIM) | United States | $0.300B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.285B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.280B | 19.29 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| 908 Devices (MASS) | United States | $0.227B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.194B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.150B | 0.00 |
| Accuray (ARAY) | United States | $0.146B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.093B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.086B | 52.50 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.061B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.047B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.92 |